Survival improvement in thalassemia: who should take the credit?

Affiliations

Comment

Antonio Piga. Haematologica. 2006 Sep.

. 2006 Sep;91(9):1154B.

¹ Department of Pediatric Hematology, Università di Torino, Italy. antonio.piga@unito.it

No abstract available

Comment on

Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.
Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M, Simamonian K, Skordos G, Sitarou M, Angastiniotis M. Telfer P, et al. Haematologica. 2006 Sep;91(9):1187-92. Haematologica. 2006. PMID: 16956817

Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.
Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M, Simamonian K, Skordos G, Sitarou M, Angastiniotis M. Telfer P, et al. Haematologica. 2006 Sep;91(9):1187-92. Haematologica. 2006. PMID: 16956817
Survival in thalassemia with conventional treatment.
Borgna-Pignatti C, Zurlo MG, DeStefano P, DiGregorio F, Di Palma A, Piga A, Melevendi C, Burattini MG, Terzoli S, Masera G. Borgna-Pignatti C, et al. Prog Clin Biol Res. 1989;309:27-33. Prog Clin Biol Res. 1989. PMID: 2675094 Clinical Trial. No abstract available.
Role of T2* magnetic resonance in monitoring iron chelation therapy.
Carpenter JP, Pennell DJ. Carpenter JP, et al. Acta Haematol. 2009;122(2-3):146-54. doi: 10.1159/000243799. Epub 2009 Nov 10. Acta Haematol. 2009. PMID: 19907152
Thalassemia. A few new tiles in a large mosaic.
Borgna-Pignatti C. Borgna-Pignatti C. Haematologica. 2006 Sep;91(9):1159-61. Haematologica. 2006. PMID: 16956812 Review. No abstract available.
Treatment of iron overload in thalassemia.
Cianciulli P. Cianciulli P. Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:208-13. Pediatr Endocrinol Rev. 2008. PMID: 19337180 Review.